Multicancer Early Detection Screening Fails to Reduce Late-Stage Cancer Incidence in Trial

The NHS-Galleri trial, published in The New England Journal of Medicine, found that annual blood-based multicancer early detection screening, when added to standard care, did not significantly lower the incidence of stage III or IV cancers across 12 specified types. This initial finding suggests that further follow-up is necessary to fully assess the long-term outcomes and overall impact of such screening methods.